IMI_EPAD Profile Banner
EPAD Profile
EPAD

@IMI_EPAD

Followers
3K
Following
4K
Media
781
Statuses
4K

Collaborative #research initiative to improve the chance of successfully preventing #Alzheimer’s #dementia. Closed project funded by @IHIEurope.

Joined January 2015
Don't wanna be here? Send us removal request.
@IMI_EPAD
EPAD
3 years
📢The @IMI_EPAD genomic data is now available on the #ADWorkbench to provide even greater value to the global neuroscience research community. #openaccess #datasharing @alzdata @aridhia @CenDemPrevent @craig_ritchie68 @IHIEurope .
Tweet media one
1
15
32
@IMI_EPAD
EPAD
5 months
👉Welcome to Day 2 of #ADPD2025!. We're pleased that several oral presentations mentioned the @IMI_EPAD project yesterday!. Interested to know more about our data? Stop by booth 16 of @AlzData to see demos of #ADWorkbench!.
Tweet media one
0
3
7
@IMI_EPAD
EPAD
6 months
📢 New paper out aiming to better inform use of Parental Onset of Dementia (POD) as a risk stratification tool in studies of late-onset Alzheimer's disease. Congratulations to all authors 👍.
Tweet card summary image
alz-journals.onlinelibrary.wiley.com
INTRODUCTION Whether temporal proximity to parental onset of dementia (PPO) can be used to estimate timing of the preclinical stage of sporadic Alzheimer's disease (AD) remains uncertain. METHODS ...
0
0
0
@IMI_EPAD
EPAD
6 months
📢New paper out perfoming a well-powered Brain Wide Association Study of the grey-matter structure in Alzheimer's disease, symptoms and progression, using a meta-analysis across 11 Cohorts including @IMI_EPAD ⤵️ .
Tweet card summary image
onlinelibrary.wiley.com
We meta-analysed results from 11 neuroimaging cohorts of elderly participants, to estimate the morphometricity (total association with brain measurements) of 17 traits of interest, and to identify...
0
0
1
@IMI_EPAD
EPAD
7 months
👉Check out this new paper assessing longitudinal brain atrophy and cognitive decline as a function of cerebrospinal fluid (CSF) AD biomarkers in the ALFA and @IMI_EPAD cohorts!. Congratulations to all authors 👏 @Raffaele_C1 .
Tweet card summary image
alz-journals.onlinelibrary.wiley.com
INTRODUCTION Identifying the link between early Alzheimer's disease (AD) pathological changes and neurodegeneration in asymptomatic individuals may lead to the discovery of preventive strategies....
@BarcelonaBeta
Barcelonaβeta Brain Research Center
7 months
🗞️ Just published!. A new groundbreaking study by Dr. Raffaele Cacciaglia (@Raffaele_C1) has shown that amyloid accumulation on its own can cause brain atrophy and cognitive decline, even without elevated levels of the tau protein.
Tweet media one
0
3
10
@IMI_EPAD
EPAD
7 months
Check out this new paper "Cerebral Microbleeds and Amyloid Pathology Estimates From the Amyloid Biomarker Study" using data from 15 research and memory clinic studies including @IMI_EPAD . Congratulations to all authors👏.
Tweet card summary image
jamanetwork.com
This cross-sectional study examines the association of amyloid pathology and APOE ε4 copy number with cerebral microbleeds among adults with and without cognitive impairment.
0
1
2
@IMI_EPAD
EPAD
9 months
RT @IMI_AMYPAD: ✨New Interview with @emmaluckettneu1, Postdoc Researcher & Data Manager at the Department of Radiology/Nuclear Medicine at….
0
2
0
@IMI_EPAD
EPAD
10 months
RT @CindyBirck: So nice to hear Elisabetta Vaudano presenting the neurodegeneration portfolio from @IHIEurope at #34AEC. @AlzheimerEurope….
0
7
0
@IMI_EPAD
EPAD
11 months
The @IMI_EPAD biobank includes blood, CSF, saliva and urine samples collected over the course of our longitudinal study. Interested in applying for sample access? Visit our website: #TimeToActOnDementia #TimeToActOnAlzheimers #WorldAlzMonth
Tweet media one
0
1
2
@IMI_EPAD
EPAD
11 months
RT @IMI_AMYPAD: We had a fantastic day yesterday at the @eumind_congress! If you're attending #EUMind2024, don’t miss @LECollij's presentat….
0
4
0
@IMI_EPAD
EPAD
11 months
Today is #WorldAlzheimerDay 🧠. Every 3 seconds someone in the world develops #dementia and there are over 55 million people around the world living with dementia🌍. #WorldAlzMonth #TimeToActOnDementia #TimeToActOnAlzheimers
Tweet media one
0
2
5
@IMI_EPAD
EPAD
11 months
The data, bio samples & neuroimaging generated from the @IMI_EPAD study are available for researchers studying the brain & neurodegenerative diseases. Visit our website for further information⤵️. #TimeToActOnDementia #TimeToActOnAlzheimers #WorldAlzMonth
Tweet media one
0
0
0
@IMI_EPAD
EPAD
1 year
🧠September is World Alzheimer’s Month, an international campaign to raise #dementia awareness and challenge stigma. 🌍Follow along with #WorldAlzMonth! . @AlzDisInt #TimeToActOnDementia #TimeToActOnAlzheimers
Tweet media one
0
6
11
@IMI_EPAD
EPAD
1 year
Want to know more about the NeuroToolKit Application developed by Roche Diagnostics & supported by @AlzData?. Check out this paper reporting its testing phase & how this tool could advance research in Alzheimer's disease⤵️.@craig_ritchie68 @JuandoGispert.
Tweet card summary image
pmc.ncbi.nlm.nih.gov
0
4
7
@IMI_EPAD
EPAD
1 year
RT @AlzData: Want something to carry your #AAIC24 materials in? . Come by booth 1224 to answer these questions and receive a free tote!.- W….
0
5
0
@IMI_EPAD
EPAD
1 year
New study out revealing distinct genetic risk profiles in association with specific pathophysiological aspects in predementia stages of Alzheimer's disease with @IMI_EPAD data!. Congrats to @LuigiLorenzini1 and all authors👏.
Tweet card summary image
alz-journals.onlinelibrary.wiley.com
INTRODUCTION Unraveling how Alzheimer's disease (AD) genetic risk is related to neuropathological heterogeneity, and whether this occurs through specific biological pathways, is a key step toward...
0
1
4
@IMI_EPAD
EPAD
1 year
RT @IMI_AMYPAD: #AAIC24 started this morning with an interactive educational session on Amyloid PET Quantification. Thanks to all speakers….
0
3
0
@IMI_EPAD
EPAD
1 year
RT @emmaluckettneu1: If you want to know more about our European Prevention of Alzheimer’s disease cohort collaboration ✨Euro-PAD✨ or want….
0
7
0